Flyte Aviation, Inc. (VJET) · Oct 9, 2026 · Share issuance
$2.05M preferred financing — 2,050,000 potential common shares at $1.00 conversion
Flyte Aviation’s new financing brings in $2.05 million, but a broad conversion-price reset sharply increases potential dilution across preferred stock.
Flyte Aviation is a newly rebranded company pivoting from medical devices toward Flyte, a private-aviation platform connecting travelers with Cirrus Vision Jets operated by its Ponderosa Air subsidiary under FAA Part 135.
The company is adding near-term capital, but the financing is not yet closed. Existing investors agreed to buy 2,050 shares of Series C-4 preferred stock for $2.05 million of gross proceeds, with closing expected around October 13, 2026. 〔0〕
| Item | Filing detail |
|---|---|
| Gross proceeds | $2.05 million (Item 3.02) |
| C-4 conversion price | $1.00 per share, reduced from $2.30 (Item 8.01) |
| Common shares issuable from new C-4 preferred | Up to 2.05 million (Item 3.02) |
| Beneficial ownership cap | 4.99%, expandable to 9.99% with notice (Item 3.02) |
| Series J conversion price | $1.00, versus $15.60 previously (Item 8.01) |
The cash helps fund the aviation transition, but the terms materially worsen dilution risk. At the new $1.00 conversion price, the incoming C-4 shares can convert into up to 2.05 million common shares. More importantly, the company also reset the conversion price of all outstanding Series C-1 through C-4, Series D, and Series J preferred stock to $1.00, creating additional potential issuance beyond the new financing.
The Series J reset is especially aggressive and appears to be the economic cost of securing holder consent. Its conversion price falls from $15.60 to $1.00, while only the shares issuable at the old $15.60 price are registered for resale; the incremental shares remain restricted. That may slow resale, but it does not remove the underlying dilution potential.
This was partly anticipated rather than a surprise financing. The purchase comes through an Additional Investment Right in the March 9, 2026 securities purchase agreement, so the direction of new capital was already embedded in the company’s financing structure; the meaningful new information is the $1.00 conversion reset across multiple preferred series.
Bottom line: Flyte gets a modest cash injection for its aviation buildout, but it pays for that capital with a much lower conversion price across a broad preferred stack. The event supports liquidity while substantially worsening the dilution overhang during the company’s transition.
Expected financing close, October 13, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!